Market Chameleon (Fri, 18-Sep 11:53 AM)
FDA Approval and New Financing Position Replimune for TUDRIQEV Launch in Advanced Melanoma
Market Chameleon (Fri, 14-Aug 9:36 AM)
Replimune’s $150 Million Offering Underscores Confidence in Oncolytic Immunotherapy Platform
Market Chameleon (Mon, 10-Aug 8:16 AM)
FDA Committee Favors RP1 for Advanced Melanoma—Upcoming Target Date Puts Replimune in the Spotlight
Market Chameleon (Fri, 31-Jul 11:07 AM)
